on 02 Aug 2022
Last Applicant/ Owned by
Am Biopark 11
Regensburg
DE
93053
Serial Number
88637718 filed on 01st Oct 2019
Registration Number
6805773 registered on 02th Aug 2022
Correspondent Address
David A Lowe
Filing Basis
1. intent to use
Disclaimer
NO DATA
Medicines, namely, medicines for the treatment of bone diseases; Medicines for the treatment of immune system related diseases and disorders; Medicines for the prevention of autoimmune diseases; Medicines for treating rheumatological diseases; Medicines for the treatment of cancer; Medicines for activating cellular function; Medicines for treating malignant tumors; Medicines for immunity adjustmenRead More
Medicines, namely, medicines for the treatment of bone diseases; Medicines for the treatment of immune system related diseases and disorders; Medicines for the prevention of autoimmune diseases; Medicines for treating rheumatological diseases; Medicines for the treatment of cancer; Medicines for activating cellular function; Medicines for treating malignant tumors; Medicines for immunity adjustment; Medicines for regulating the immune system; Medicines for the treatment of autoimmune diseases; Medicines for use in chemotherapy; Medicines for use in oncology; Medicines and pharmaceutical substances for the treatment of cancer; Medicines and pharmaceutical substances for the prevention of cancer; Medicines and pharmaceutical substances for use in oncology; Medicines for the treatment of Parkinson's disease; Medicines for the treatment of central nervous system diseases; Medicines for the treatment of multiple sclerosis; Medicines for peripheral nervous system; Medicines for the treatment of epilepsy; Medicines for treating sensory organ disorders; Medicines for the prevention of disorders of the immune system; Medicines for use in tissue transplantation; Medicines for use in organ transplantation; Medicines for the prevention of disorders of the nervous system; Medicines for the prevention of diseases of the nervous system; Diagnostic preparations for medical purposes and diagnostic materials, namely, diagnostic agents for medical purposes, diagnostic substances for medical purposes; Biochemical preparations for medical use, namely, for treatment of cancer; Chemical preparations for medical purposes, namely, for treatment of cancer; Cardiovascular agents for medical purposes; Medicinal healthcare preparations for treatment of cancer; Medical preparations for treatment of cancer; Cellular function activating agents for medical purposes; Nucleic acid sequences for medical purposes; Organotherapeutics; Reagents for medical use; Stem cells for medical use; Pre- filled syringes for medical purposes, filled with medicine for treatment of cancer; Anti-cancer drugs, namely, Anti-cancer preparations, Pharmaceutical products for the prevention and treatment of cancer; Medicines for intestinal disorders; Medicines for the treatment and prevention of lung disorders; Medicines for the treatment and prevention of liver disorders; Medicines for the treatment and prevention of kidney disorders; Medicines for the treatment and prevention of reproductive organ disorders; Medicines for the treatment and prevention of heart and heart valve disorders; Medicines for genetic reprogramming of cells and organs for prevention of intestinal disorders; Medicines for the treatment of the nervous system; Medicines for the treatment of brain and spinal cord trauma including paraplegia; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use, namely, genetically engineered biological preparations for the treatment of cancer; Chemico-pharmaceutical preparations for treatment of cancer; Chemicals for pharmaceutical use, namely, chemical reagents for pharmaceutical or medical purposes; Chemical preparations for pharmaceutical medical purposes for treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, for treatment of cancer; Anti-cancer preparations of chemical origin; Chemotherapeutics; Cardiovascular treatment preparations; Immunomodulators being a type of pharmaceutical preparation for the treatment of immune system related diseases and disorder; Immunoassay reagents for medical use; Immunostimulants; Antitumor drugs, namely, Tumor suppressing agents; Nervines, namely, for treatment of nervous system; Tissue-regenerative pharmaceutical preparations; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for treating rheumatological diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for treating sensory organ disorders; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical preparations for use in organ transplantation; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Compounds for treating cancer, namely, Drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for treating cancer, Biometallic compounds being a component in pharmaceutical preparations for treating cancer; Central nervous system stimulants; Tumor suppressing agents; Ethical medicinal preparations for treatment of cancer, use in dermatology; Cytostatics for medical purposes; Bacteriological preparations for medical use; Biological reagents for medical use; Diagnostic chemical reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis for medical purposes; Pharmaceuticals for the therapy and prophylaxis of neurodegenerative diseases; Pharmaceuticals for the therapy and prophylaxis of Morbus Alzheimer, Morbus Parkinson, Morbus Huntington, amyotrophic lateral sclerosis (ALS), acquired immunodeficiency syndrome AIDS dementia, Retinitis pigmentosa, spinal muscular atrophy, cerebellar degeneration, fragile X-associated tremor/ataxia syndrome (FXTAS), progressive supranuclear palsy (PSP), striatonigral degeneration (SND), Shy-Drager syndrome (SDS); Pharmaceuticals for the therapy and prophylaxis of multiple system atrophy (MSA), parkinsonian type (MSA-P) or formerly olivopontocerebellar atrophy (OPCA), all of the entities of hydrocephalus including normal pressure hydrocephalus, paraplegia, condition after hypoxia and resuscitation, cognitive deficiencies after inflammatory or infectious CNS disorders; Pharmaceuticals for the therapy and prophylaxis of forms of fibrotic tissue transformation including presbycusis, presbyopia, glaucoma, forms of pulmonary fibrosis, including Idiopathic pulmonary fibrosis (IPF), liver cirrhosis, kidney diseases, gynecological disorders, keloid formations after trauma; Chemical and biological products, namely, diagnostic preparations for medical purposes for diagnosing neurodegenerative diseases, pulmonary diseases, liver cirrhosis, oncological diseases; Diagnostic preparations, in particular, diagnostics preparations for medical purposes and for diagnosing central nervous system (CNS) disorders, forms of fibrotic tissue transformations, pulmonary diseases, liver cirrhosis, kidney diseases, gynecological disorders, oncological diseases
Medical apparatus for the treatment of cancer; Medical apparatus for the treatment of lung ailments; Medical apparatus for the treatment of disease of the prostate; Medical apparatus for taking body fluid samples; Apparatus for medical cell sampling for medical use in testing cancer levels; Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus for use in the diagnosis of metabolic disorders; Medical apparatus for administering intravenous solutions for use in general surgery; Applicators for medications, namely, medical apparatus for introducing pharmaceutical preparations into the human body; Medical applicators for introducing pharmaceutical preparations into the human body; Automatic medical apparatus for dosing humans with pharmaceutical preparations, medical drugs by injection; Metering pumps for delivering drugs in measured quantities, for medical use and sold empty; Electronic nerve stimulators for medical use; Electronic muscle stimulators for medical use; Electrophoresis apparatus for medical use; Medical apparatus for tumor diagnosis; Apparatus for administering pharmaceuticals, namely, infusion and injection medical devices for administering pharmaceutical drugs, medical tubing for administering pharmaceutical drugs; Infusion apparatus, namely, infusion sets for therapeutic purposes; Inhalers, namely, Inhalers for therapeutic use and sold empty, Oxygen inhalators for medical use and sold empty; Inhalers for the evaporation of para-medical substances for medical purposes; Inhalers for medical use; Injection device for pharmaceuticals; Medication injectors, namely, medication injection instruments with needles, medical apparatus in the nature of an injection device for administering drugs; Medical imaging apparatus for neurographic purposes; Medical apparatus for introducing pharmaceutical preparations; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Pumps implantable drug delivery pumps for medical use in delivering pharmaceuticals from containers; Specimen samplers for medical use, namely, medical apparatus for taking blood samples, Sample preparation device for medical diagnostic uses; Medical syringes; Hypodermic needles for injection; Hypodermic syringes for use in administering injection substances; Portable nebulisers for medical purposes; Nebulizers for medical use; Medical apparatus, namely, Surgical apparatus and instruments for medical use
Science and technology services, namely, Scientific research, Research and development of technology in the field of pharmaceuticals; Medical and pharmacological research services; Consultancy relating to research in the field of pharmacogenetics; Consultancy relating to pharmaceutical research and development; Consultancy relating to scientific, product research and development in the field of therapeutics; Consultancy pertaining to pharmacology; Consultancy in the field of pharmaceutical research; Consultancy relating to laboratory testing; Provision of information and data in the nature of scientific research information relating to medical research and development; Providing scientific research, product research information about the results of clinical trials for pharmaceutical products; Pharmaceutical product evaluation; Biological research, clinical research in the field of cancer treatment, radiology, chemotherapy, coronary artery bypass surgery and medical research; Biomedical research services; Medical research laboratory services; Medical laboratory services; Services in the nature of product testing for assessing the efficiency of pharmaceuticals; Testing of pharmaceuticals; Conducting clinical trials for pharmaceutical products performed for others; Analysis of human tissues performed for medical research purposes; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research in the field of cancer treatment, radiology, chemotherapy, coronary artery bypass surgery; Scientific research in the nature of conduction clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical drug development services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and development; Scientific research for medical purposes in the field of cancer, forms of fibrotic tissue transformations, nervous system disorders, forms of pulmonary fibrosis including idiopathic pulmonary fibrosis (IPF), liver cirrhosis, and brain and spinal cord trauma diseases including paraplegia; Scientific investigations for medical purposes; Growing of tissue performed as part of scientific research services, medical research services; Contract research and contract development of pharmaceuticals; Contract research and contract development of pharmaceuticals, medicines for the therapy of neurodegenerative diseases scientific, product research and development in the medical, pharmaceutical, pharmacological, biochemical, genetic engineering and medical technology fields, for others; Contract clinical tests and clinical studies, namely, scientific research in the nature of conducting clinical trials for others; Providing scientific expertise, in particular, providing scientific research and development services, scientific research consulting in the field of pharmaceuticals for scientific projects, clinical trials and clinical studies; Consultancy and Information services relating to product development, product research of medical product; Advisory services relating to product development, product research of medical apparatus and instruments; Consultancy and information services relating to product development, product research of pharmaceutical products; Consultancy and information services relating to product development, product research of biopharmaceutical products
Human healthcare services; Medical services; Health advice and information services; Professional consultancy relating to health care; Advisory services relating to health; Laboratory analysis services relating to the treatment of persons, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and healthcare services; Stem cell storage services, namely, isolation, collection, and banking of umbilical cord tissue perivascular stem cells; Advisory services relating to the treatment of degenerative diseases; Providing news and information in the field of medicine; Advisory services relating to medical diagnosis services, healthcare treatments services relating to degenerative diseases; Consultancy and information services relating to medical products, namely, consultancy and information services relating to rental of medical equipment, consultancy and information services relating to medical services involving medical products; Advisory services relating to medical apparatus and instruments, namely, consultancy and information services relating to medical services involving medical apparatuses and instruments; DNA screening for medical purposes; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical analysis services for the diagnosis of cancer; Medical screening; Medical services featuring RNA or DNA analysis for cancer diagnosis and prognosis; Providing cancer screening services; Genetic testing for medical purposes; Individual medical counseling services provided to patients; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services relating to the treatment of persons; Medical analysis for diagnostic and treatment purposes provided by medical laboratories; Medical analysis for the diagnosis and treatment of persons; Medical diagnostic testing, monitoring and reporting services; Medical services in the field of oncology; Medical services relating to the removal, treatment and processing of bone marrow; Medical services relating to the removal, treatment and processing of stem cells; Medical services relating to the removal, treatment and processing of human blood; Medical services relating to the removal, treatment and processing of human cells; Medical and health assessment services relating to DNA, genetics and genetic testing; Medical services for the diagnosis of conditions of the human body; Medical services, namely, analysis of human tissues for medical treatment; Medical services, namely, analysis of human serum for medical treatment; Pharmaceutical services, namely, pharmaceutical advice, dispensing of pharmaceuticals; Provision of information relating to medicine; Provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Pharmacy advice, namely, pharmaceutical advise; Consultancy and information services in the field of pharmaceutical advice, healthcare information relating to pharmaceutical products; Consultancy and information services in the field of pharmaceutical advice, healthcare information relating to biopharmaceutical products; Preparation and dispensing of medications; Providing information relating to the preparation and dispensing of medications
No 88637718
No Service Mark
No VELV-2-0001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 02th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Jun 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 29th Dec 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 14th Dec 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Dec 2021 | PUBLISHED FOR OPPOSITION |
| 24th Nov 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th Nov 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 05th Nov 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 05th Nov 2021 | EXAMINER'S AMENDMENT ENTERED |
